AVERA MCKENNAN — History
CCN 430016 | 3-year financial timeline | COVID resilience: 56/100
🛡️ Public data only — no PHI permitted on this instance.
$1.3B
Latest Revenue (FY2022)
+0.5%
Revenue CAGR (3yr)
-9.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $1.3B | $1.2B | $1.3B | +8.2% | +0.5% |
| Operating Expenses | $1.5B | $1.4B | $1.5B | +4.8% | +0.5% |
| Operating Margin | -9.8% | -13.4% | -9.9% | +26.6% | +0.0% |
| Net Income | $-130M | $-167M | $-132M | +20.6% | +0.0% |
| Licensed Beds | 503 | 521 | 547 | +5.0% | +4.3% |
| Total Patient Days | 128,523 | 133,754 | 131,751 | -1.5% | +1.2% |
| Medicare Day % | 31% | 29% | 30% | +1.9% | -3.0% |
| Medicaid Day % | 16% | 17% | 16% | -5.7% | +0.8% |
COVID Impact & Recovery
Resilience Score: 56/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +0.9% ($1.3B → $1.3B)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▶ Stable
Operating Margin▲ Growing
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+0.5%
This Hospital
+7.6%
State Avg
Latest Margin
-9.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $1.3B | -9.9% |
| FY2024 (proj) | $1.4B | -10.0% |
| FY2025 (proj) | $1.4B | -10.0% |